We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,930.00
Bid: 1,920.00
Ask: 1,921.00
Change: 17.00 (0.89%)
Spread: 1.00 (0.052%)
Open: 1,921.00
High: 1,930.00
Low: 1,901.00
Prev. Close: 1,913.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks advance despite economic worries

Fri, 01st Oct 2010 12:23

London's leading share index remains in positive territory, but worries over the European debt situation have weighed on sentiment slightly.The concerns centre on Ireland again, after figures showed manufacturing activity in the country contracted in September, with the purchasing managers' index falling to 48.4 from 51.1 in August. A reading above 50 indicates expansion.Manufacturing figures here were much better, but nothing to shout about. The Markit/Chartered Institute of Purchasing and Supply manufacturing PMI index fell to 53.4 in September from 53.7 the previous month, suggesting growth figures for the third quarter will be subdued.Despite the gloom, there was some positive company news for traders to ponder. BP is higher amid speculation that dividends will soon be resumed. Bob Dudley, who becomes chief executive of the oil company today, said that the board would meet soon to discuss restoring payouts next year, according to newspaper reports. But it is BP's rival BG that is causing most excitement. BG's Spanish peer Repsol has announced a deal with the Chinese refiner Sinopec, which will result in Sinopec holding a 40% stake in Repsol's Brazilian unit. BG Group and Repsol have been exploring for oil in waters of Brazil in partnership and the deal is also seen as supportive to BG.In the FTSE 250, drugs group Hikma Pharmaceuticals has moved to calm fears about the impact of a plan by US regulators to ban unapproved oral colchicine products to treat gout. The company said it will comply with any FDA regulatory requirements related to the sale of colchicine "if such a notice is served", but still predicts 20% revenue growth for its US generics business for the full year 2010 "irrespective of the timing of such notification".Having thought about it all week Cooper Controls has launched a rival bid for Mount Engineering at 82p a share, topping Redhall's 70p a share offer. Spectris, the mid-cap instrumentation and controls company, has bought American maker of rugged industrial networking components N-TRON for $51m (£32m).FTSE 100 - RisersBG Group (BG.) 1,166.00p +4.25%ARM Holdings (ARM) 404.50p +3.14%BP (BP.) 440.60p +2.99%Land Securities Group (LAND) 656.50p +2.50%Weir Group (WEIR) 1,458.00p +2.46%Capital Shopping Centres Group (CSCG) 375.90p +2.23%Vedanta Resources (VED) 2,206.00p +1.89%Tullow Oil (TLW) 1,298.00p +1.88%African Barrick Gold (ABG) 600.00p +1.69%Lonmin (LMI) 1,697.00p +1.68%FTSE 100 - FallersExperian Group (EXPN) 682.50p -1.52%Cobham (COB) 227.90p -1.34%Compass Group (CPG) 524.00p -1.23%Aggreko (AGK) 1,551.00p -1.21%Rolls-Royce Group (RR.) 597.00p -1.08%Resolution (RSL) 243.00p -0.82%Morrison (Wm) Supermarkets (MRW) 293.30p -0.81%Aviva (AV.) 395.80p -0.78%Burberry Group (BRBY) 1,032.00p -0.77%Severn Trent (SVT) 1,301.00p -0.76%FTSE 250 - RisersPace (PIC) 181.20p +4.14%Victrex (VCT) 1,328.00p +4.08%TalkTalk Telecom Group (TALK) 152.50p +3.95%Helical Bar (HLCL) 308.10p +3.53%Hargreaves Lansdown (HL.) 454.90p +3.39%Mondi (MNDI) 530.00p +3.01%Great Portland Estates (GPOR) 351.40p +2.96%Shaftesbury (SHB) 445.20p +2.84%Electrocomponents (ECM) 249.70p +2.84%Derwent London (DLN) 1,546.00p +2.79%FTSE 250 - FallersYell Group (YELL) 14.40p -2.51%CPP Group (CPP) 260.00p -2.44%Moneysupermarket.com (MONY) 80.45p -1.83%Hochschild Mining (HOC) 437.00p -1.80%CSR (CSR) 352.70p -1.75%Howden Joinery Group (HWDN) 75.25p -1.51%United Business Media (UBM) 620.00p -1.51%Hansen Transmissions International (HSN) 46.90p -1.47%Supergroup (SGP) 1,198.00p -1.40%Stobart Group Ltd. (STOB) 152.20p -1.36%
More News
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.